Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries

Autor: Konstantin Tachkov, Francisco Somolinos-Simón, Jose Tapia-Galisteo, Maria Elena Hernando, Gema García-Sáez, Maria Dimitrova, Maria Kamusheva, Zornitsa Mitkova, Zsuzsanna Petyko, Bertalan Nemeth, Zoltan Kalo, Tomas Tesar, Marian-Sorin Paveliu, Oresta Piniazhko, Iga Lipska, Adina Turcu-Stiolica, Alexandra Savova, Manoela Manova, Rok Hren, Petra Došenović Bonča, Saskia Knies, Michal Stanak, Tomáš Doležal, Dinko Vitezic, Guenka Petrova

Publikováno v: Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)

This study aimed to investigate the transferability of novel artificial intelligence (AI) methods for prediction modelling of diabetes based on real-world data (RWD) between early and late adopters of emerging health technologies from the perspective

Externí odkaz: https://doaj.org/article/6868ed8c409341fb99bd9cda75a78575

Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies

Autor: Luke Vale, Elena Olariu, Marian Sorin Paveliu, Eugen Baican, Yemi Oluboyede, Ileana Gabriela Niculescu-Aron

Publikováno v: BMJ Open, Vol 9, Iss 8 (2019)

Introduction The importance of health-related quality of life (HRQoL) is increasing and many healthcare authorities recommend the use of measures that account for both mortality and morbidity. This study will determine, for the first time in Romania,

Externí odkaz: https://doaj.org/article/164b12eb050c453092c7982a8fbe80b7

Population norms for the Romanian version of EQ-5D-3L and EQ-5D- 5L

Autor: Elena Olariu, Raluca Caplescu, Luke Vale, Ileana Gabriela Niculescu-Aron, Yemi Oluboyede, Marian Sorin Paveliu

Background The majority of patient reported outcome measures (PROMs) don’t have population norms in Romania. This is the case with the EQ-5D as well. Therefore, we aimed to estimate population norms for the Romanian versions of the EQ-5D-5L, EQ-5D-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f97c23472859d1c62b0d06229683543
https://doi.org/10.21203/rs.3.rs-2144821/v1

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Autor: Wojciech Trąbka, Guenka Petrova, Manoela Manova, Christoph Sowada, Pero Draganić, Agnes Männik, Alexandra Savova, Krzysztof Piotr Malinowski, Kristóf Márky, Marian Sorin Paveliu, Tomas Tesar, Paweł Kawalec, Juraj Slabý, Zinta Rugaja, Jolanta Gulbinovič

Publikováno v: Orphanet journal of rare diseases, London : BioMed Central, 2020, vol. 15, no. 1, art. no. 277, p. [1-13]
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-13 (2020)

Background The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive descriptio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e500972dee9ea52912420e7fe38731d0
https://www.bib.irb.hr/1223202

Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania

Autor: Corina Mogoșan, Catalin Codreanu, Marian-Sorin Paveliu, Claudiu C. Popescu

Publikováno v: BioMed Research International
BioMed Research International, Vol 2019 (2019)

Rheumatoid arthritis (RA) is associated with increased costs generated by resource utilization and loss of work productivity. We have studied 206 RA patients and analyzed indirect costs of RA in Romania (estimated using the human capital approach) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e264b9d581e8af0967e8debcd7831e2
https://pubmed.ncbi.nlm.nih.gov/31346527